This study investigates pancreatic cancer. The purpose of this study is to explore how different investigational medications work in patients with this condition.
The study evaluates the safety and tolerability of the investigational medications. It also looks at changes in tumor biology and potential biomarkers.
- Who can participate: Adults aged 18 and older with pancreatic cancer may participate. Eligibility includes having resectable, borderline resectable, locally-advanced, or metastatic adenocarcinoma of the pancreas and the ability to undergo tumor biopsies.
- Study details: Participants will receive an investigational medication. They will undergo biopsies or surgery as part of the study.
How understandable was the trial content above?
Hard to understand
Easy to understand